Brain Health Program for Alzheimer Disease

Phase-Based Progress Estimates
Posit Science Corporation, San Francisco, CA
Alzheimer Disease+1 More
Brain Health Program - Other
All Sexes
What conditions do you have?

Study Summary

This is a validation study to evaluate the acceptability, feasibility and preliminary efficacy of the Brain Health Program, a multimodal curriculum covering dementia risk factors and evidence-based change interventions. The goal of this study is to evaluate the Brain Health Program in individuals with identified risk factors for the onset of dementia and to prepare for a large-scale efficacy trial in this population.

Eligible Conditions

  • Alzheimer Disease
  • Dementia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: At 12 weeks

At 12 weeks
Net Promoter Score

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Brain Health Program
1 of 1
Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Brain Health Program · No Placebo Group · N/A

Brain Health Program
Experimental Group · 1 Intervention: Brain Health Program · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at 12 weeks
Closest Location: Posit Science Corporation · San Francisco, CA
Photo of San Francisco  1Photo of San Francisco  2Photo of San Francisco  3
2006First Recorded Clinical Trial
1 TrialsResearching Alzheimer Disease
13 CompletedClinical Trials

Eligibility Criteria

Age 65+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are 65 years of age or older.\n
You must have adequate sensorimotor capacity to perform the program, including visual capacity adequate to read from a computer screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a computer mouse or a tablet.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.